000344752 001__ 344752
000344752 005__ 20230827173512.0
000344752 0247_ $$2CORDIS$$aG:(EU-Grant)190131747$$d190131747
000344752 0247_ $$2CORDIS$$aG:(EU-Call)HORIZON-EIC-2022-ACCELERATOR-01$$dHORIZON-EIC-2022-ACCELERATOR-01
000344752 0247_ $$2originalID$$acorda_____he::190131747
000344752 035__ $$aG:(EU-Grant)190131747
000344752 150__ $$aA minimally invasive and durable endograft fastening solution for Abdominal Aortic Aneurysm (AAA)$$y2023-02-01 - 2025-01-31
000344752 372__ $$aHORIZON-EIC-2022-ACCELERATOR-01$$s2023-02-01$$t2025-01-31
000344752 450__ $$aaortoseal$$wd$$y2023-02-01 - 2025-01-31
000344752 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000344752 680__ $$aAbdominal aortic aneurysm (AAA) is a focal enlargement of the abdominal aorta below the renal arteries and is found in up to 4 million patients globally each year. If left untreated it can be fatal, so it is imperative to provide early, prophylactic treatment before a rupture occurs. The available treatment options are far from optimal: open surgery is a durable, life-long, but high-risk solution. The alternative, EVAR, has lower immediate risks, but is a shorter-term solution and requires continual monitoring and secondary interventions.
We have developed Aortoseal, a fixation and sealing implant for endovascular aneurysm repair that combines the best of both worlds: the stability of an open, sutured repair and the safety and low-risk delivery of EVAR. Aortoseal will reduce the need for open surgery, the need for secondary procedures and time in the hospital, all leading to improved patient outcomes and projected healthcare savings over a 10 year period of ~€9 bn across the EU.
000344752 909CO $$ooai:juser.fz-juelich.de:1014112$$pauthority:GRANT$$pauthority
000344752 909CO $$ooai:juser.fz-juelich.de:1014112
000344752 980__ $$aG
000344752 980__ $$aCORDIS
000344752 980__ $$aAUTHORITY